Bluebird bio sec filings

Author: wwfg

August undefined, 2024

WebFind the latest SEC Filings data for bluebird bio, Inc. Common Stock (BLUE) at Nasdaq.com. WebAug 4, 2024 · Inside Bluebird Bio, Inc.'s 10-Q Quarterly Report: Financial - Expense Highlight. The decrease of $18.3 million was primarily due to the following: $25.3 million of decreased employee compensation, benefit, and other headcount-related expenses, which is primarily driven by a decrease of $9.1 million in stock-based compensation expense …

Bluebird Bio, Inc. (BLUE) 8-K Earnings Release, Event for Officers ...

WebApr 14, 2024 · The firm owned 5,924 shares of the basic materials company’s stock after buying an additional 1,370 shares during the quarter. IFG Advisory LLC’s holdings in Celanese were worth $605,000 as of its most recent SEC filing. Other institutional investors and hedge funds have also recently bought and sold shares of the company. WebThis will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect … briche thierry

Jason Cole - Strategy and Corporate Development Advisor

WebMar 29, 2024 · Bluebird Bio, Inc. (BLUE) SEC Filing 8-K Material Event for the period ending Friday, March 24, 2024. ... SEC Filings. BLUE Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. Manager Portfolios. Notifications. BLUE Annual Reports. 10-K Annual Report March 2024 10-K Annual Report March 2024 10-K Annual … WebMar 10, 2024 · Verition Fund Management LLC acquired a new stake in bluebird bio, Inc. (NASDAQ:BLUE - Get Rating) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC).The fund acquired 36,737 shares of the biotechnology company's stock, valued at approximately $233,000. WebJun 30, 2024 · bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days. With a dedicated focus on severe genetic diseases, … covered bridges in germany

bluebird bio Reports First Quarter 2024 Financial Results and ...

SEC.gov Bluebird Bio, Inc.

WebApr 5, 2024 · bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days. With a dedicated focus on severe genetic diseases, … WebAnnual report which provides a comprehensive overview of the company for the past year. Annual Filings. View HTML. 0000950170-23-004757.rtf. 0000950170-23-004757.xls. 0000950170-23-004757.pdf. 02/27/23. 4. Statement … covered bridges in fairfield county ohioWebAug 9, 2024 · CAMBRIDGE, Mass. – August 9, 2024 – bluebird bio, Inc. (NASDAQ: BLUE) today reported financial results and business highlights for the second quarter ended June 30, 2024 and provided operational updates, including the announcement that the U.S. Food and Drug Administration (FDA) placed a clinical hold on clinical studies of elivaldogene … brichete foc leroy

"WebNov 5, 2024 · SEC Filings. Stock. Stock Quote & Chart Analyst Coverage. IR Resources. ... uncertainties, and other important factors in our subsequent filings with the Securities and Exchange Commission. All information in this press release is as of the date of the release, and bluebird bio undertakes no duty to update this information unless required by ... " - Bluebird bio sec filings

Bluebird bio sec filings

SEC Filings - Acadia Pharmaceuticals Inc.

WebAnnual report which provides a comprehensive overview of the company for the past year. Annual Filings. 0001467623-23-000012.pdf. 0001467623-23-000012.rtf. 0001467623-23-000012.xls. EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML. Feb 17, 2024. 4. Statement of changes in beneficial ownership of securities. WebMay 21, 2024 · On May 21, 2024, bluebird bio, Inc. (“bluebird”) issued a press release to announce that it received a positive opinion recommending marketing authorization from …

Did you know?

WebApr 14, 2024 · Cookson Peirce & Co. Inc. purchased a new position in bluebird bio, Inc. (NASDAQ:BLUE – Get Rating) during the 4th quarter, according to its most recent filing … Webbluebird bio Inc. BLUE: Leiderman Elisabeth Director: 1,004: $6.4643: $6,490: 11,466 (Direct) View: 2024-01-11 Sale: 2024-01-13 4:19 pm: bluebird bio Inc. BLUE: …

WebMar 15, 2024 · SEC Filings. Annual report which provides a comprehensive overview of the company for the past year. Securities offered to employees pursuant to employee benefit plans. A statement of beneficial ownership of common stock by certain persons. Statement of changes in beneficial ownership of securities. Statement of changes in beneficial … WebChief Strategy and Financial Officer. bluebird bio is a pioneering gene and cell therapy company focused on severe genetic diseases and cancer, including sickle cell disease, β-thalassemia ...

Webbluebird bio Inc. SEC filings breakout by MarketWatch. View the BLUE U.S. Securities and Exchange Commission reporting information. WebDec 31, 2024 · Media Contacts. Jess Rowlands. Head of Corporate Communications (857) 299-6103. [email protected]. Investor Contacts. Courtney O’Leary. …

WebApr 14, 2024 · Balentine LLC lessened its stake in Molson Coors Beverage (NYSE:TAP – Get Rating) by 18.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,094 shares of the company’s stock after selling 3,737 shares during the period. Balentine LLC’s holdings in …

Web10 rows · Mar 29, 2024 · SEC Filing Keyword Search Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions ... Sarah Alspach joined the flock in September 2024 as Chief … briche transport limogesWebAug 4, 2024 · Inside Bluebird Bio, Inc.'s 10-Q Quarterly Report: Financial - Expense Highlight. The decrease of $18.3 million was primarily due to the following: $25.3 million … brichet laetitiaWebPost-effective Amendment to an automatic shelf registration of Form S-3ASR or Form F-3ASR. March 01, 2024. 8-K. Current report filing. February 28, 2024. 4. Statement of Changes in Beneficial Ownership. February 28, 2024. 4. brichete pt focWebApr 10, 2024 · 10 analysts have issued twelve-month price objectives for bluebird bio's shares. Their BLUE share price forecasts range from $3.00 to $10.00. On average, they expect the company's share price to reach $6.78 in the next year. This suggests a possible upside of 118.6% from the stock's current price. brichete rumegus smart conserv pancotaWebMar 29, 2024 · Bluebird Bio, Inc. (BLUE) SEC Filing 10-K Annual Report for the fiscal year ending Saturday, December 31, 2024. ... 10-K Annual Report Wed Mar 29 2024; SEC Filings. BLUE Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. Manager Portfolios. Notifications. BLUE Annual Reports. 10-K Annual Report … covered bridges in indiana golfWebMay 21, 2024 · On May 21, 2024, bluebird bio, Inc. (“bluebird”) issued a press release to announce that it received a positive opinion recommending marketing authorization from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for SKYSONA™ (elivaldogene autotemcel, Lenti-D™), a one-time gene … bricheton boulangerieWebSEC Filings. Group. Filing year. Filing date Form Description Filing Group View; Apr 05, 2024: PRE 14A: A preliminary proxy statement providing notification matters to be brought to a vote ... Proxy Filings. 0001628280-23-010849.pdf. 0001628280-23-010849.rtf. 0001628280-23-010849.xls. EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA … brichet martial